Navigation Links
Diabetes a risk factor for postpartum depression
Date:2/24/2009

BOSTON, Mass. (Feb 23, 2009) Postpartum depression is a seriousand often undiagnosedcondition affecting about 10 to 12 percent of new mothers. Some of the causes might include personal history of depression, stressful life events, and lack of social, financial or emotional support. Left untreated, it can have lasting negative effects not only on the mother but on her child's development.

In the first study of its kind, investigators at Harvard Medical School and the University of Minnesota School of Public Health report that low-income women with diabetes have a more than 50% increased risk of experiencing this serious illness.

"While previous studies have linked diabetes and depression in the general population, this is the first time, to our knowledge, that the relationship has been studied specifically in pregnant women and new mothers," says Katy Backes Kozhimannil, research fellow in the Department of Ambulatory Care and Prevention at Harvard Medical School and Harvard Pilgrim Health Care. "We believe these findings may help clinicians better identify and treat depression in new mothers."

These findings are published in the February 25 edition of JAMA, the Journal of the American Medical Association.

For over 25 years, clinicians have been aware that new mothers are at risk for postpartum depression. However, the condition is difficult to identify. Many symptoms are attributed to the every-day struggles of being a new mother. Others, such as irrational thoughts about harming the baby or, conversely, obsessing over the baby's health, are simply difficult for new mothers to admit.

To investigate the potential link between diabetes and postpartum depression, Kozhimannil and Bernard Harlow, professor in the University of Minnesota's School of Public Health, examined medical claims data from the New Jersey Medicaid program, looking at information from 11,024 new mothers who had given birth between July 2004 and September 2006. All women in the study were eligible for Medicaid 6 months prior to and one year after delivery and had incomes less than 115% of the federal poverty line ($24,000 for a family of four in 2006).

The researchers identified a woman as having depression if her records indicated a diagnosis, or if she had filled a prescription for an antidepressant medication during the study period. (Diabetes was also identified using both diagnosis and prescription information.)

Study data indicated that 9.6 percent of women with diabetes, who had no indication of depression during pregnancy, developed depression during the year following delivery, compared with 5.9 percent of women without diabetes. Put another way, pregnant women and new mothers with diabetes were approximately 55 to 60 percent more likely to experience postpartum depression. The increased risk of postpartam depression is similar for women who already had diabetes and those who developed it during pregnancy.

The researchers caution that these findings do not establish that diabetes causes postpartum depression, only that the two are related. Also, the medical claims data they used did not contain information on personal or family history of depression, weight or body mass index. Plus, it isn't yet clear the extent to which one can generalize findings from such a specific and localized population.

Still, according to Kozhimannil, "Health care facilities and clinicians that serve low-income and Medicaid populations may want to pay particular attention to managing the mental health concerns of women with diabetes during pregnancy and the postpartum period."


'/>"/>

Contact: David Cameron
david_cameron@hms.harvard.edu
617-432-0441
Harvard Medical School
Source:Eurekalert

Related medicine news :

1. Diabetes Linked to Depression During and After Pregnancy
2. Pennsylvanians May Donate Part of Tax Refund to Support Juvenile Diabetes Research
3. Grammy-nominated Singer Angie Stone Encourages African-Americans in Birmingham to Fearlessly FACE Diabetes
4. One in Five Augustans With Type 2 Diabetes Mistakenly Believe That Being Obese or Overweight Can Positively Impact Their Disease
5. LSUHSC research may benefit diabetes by increasing understanding of how to control islet cell growth
6. Novo Nordisk Appoints Andy Ajello as Vice President for National Diabetes Sales, Managed Care and Government Accounts
7. GSK Initiates Phase III Programme for Novel Type 2 Diabetes Medication, Syncria(R) (albiglutide)
8. Cardiovascular Disease and Diabetes: New Blog and Slide Presentation on the Diabetes Best Practices Website Discuss the Most Recent Studies in this Field
9. PDHI Adds Diabetes and Heart Disease Prevention to ConXus Steps Library of Action Plans
10. Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes
11. Roche Announces Significant Price Reduction of Two ACCU-CHEK(R) Glucose Monitoring Kits to Help Customers With Diabetes During These Difficult Economic Times
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce ... process has been in place since the RBMA was founded in 1968 with all ... Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the chief executive officer for ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... and College of Urgent Care Medicine will host industry leaders for the annual ... will help those in the industry adapt to the issues currently affecting urgent ...
(Date:4/28/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has ... which He does not. Yisrayl says with so many titles and names for the ... he says with a little Scripture, backed with a lot of research, the truth is ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... skincare and advanced nutraceutical supplements, through its Nova Skin Sciences division, recently ... hydrating benefits of a moisturizer with the power of an anti-aging concentrate. ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-na├»ve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
Breaking Medicine Technology: